Annual Drug Patent Expirations for TOLAK Tolak is a drug marketed by Hill Dermaceuticals and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Hill Dermaceuticals drug TOLAK appeared firs…
New patent expiration for Hill Dermaceuticals drug TOLAK Read Post »
Annual Drug Patent Expirations for NUEDEXTA Nuedexta is a drug marketed by Avanir Pharms and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Avanir Pharms drug NUEDEXTA appeared firs…
New patent expiration for Avanir Pharms drug NUEDEXTA Read Post »
Annual Drug Patent Expirations for NUEDEXTA Nuedexta is a drug marketed by Avanir Pharms and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Avanir Pharms drug NUEDEXTA appeared firs…
New patent expiration for Avanir Pharms drug NUEDEXTA Read Post »
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Novartis Pharms drug ENTRESTO appeared firs…
New patent expiration for Novartis Pharms drug ENTRESTO Read Post »
Annual Drug Patent Expirations for AXIRON Axiron is a drug marketed by Eli Lilly And Co and is included in one NDA. There are seven patents protecting this drug and…
The post New patent expiration for Eli Lilly drug AXIRON appeared first on DrugPatentW…
AXIRON (testosterone) Eli lilly and co Patent: 8,784,878 Expiration: Jul 13, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for the We…
Drug Patent Expirations for the Week of July 9, 2023 Read Post »
Annual Drug Patent Expirations for XURIDEN Xuriden is a drug marketed by Wellstat Therap and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Wellstat Therap drug XURIDEN appeared first …
New patent expiration for Wellstat Therap drug XURIDEN Read Post »
Annual Drug Patent Expirations for VISTOGARD Vistogard is a drug marketed by Wellstat Therap and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Wellstat Therap drug VISTOGARD appeare…
New patent expiration for Wellstat Therap drug VISTOGARD Read Post »
Annual Drug Patent Expirations for XTAMPZA+ER Xtampza Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Collegium Pharm drug XTAMPZA ER appeared fir…
New patent expiration for Collegium Pharm drug XTAMPZA ER Read Post »
LEVITRA (vardenafil hydrochloride) Bayer hlthcare Patent: 8,841,446 Expiration: Jul 3, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of July 2, 2023 Read Post »